EMD-42521
Structure of Lassa virus glycoprotein (Josiah) on the surface of VSVdG-Lassa-GPC vaccine particle.
EMD-42521
Single-particle14.0 Å
Deposition: 30/10/2023Map released: 09/04/2025
Last modified: 09/04/2025
Sample Organism:
Lassa virus Josiah
Sample: Lassa virus Josiah
Deposition Authors: Enriquez AS
,
Saphire EO
Sample: Lassa virus Josiah
Deposition Authors: Enriquez AS
,
Saphire EO
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials.
Cooper CL ,
Morrow G,
Yuan M,
Postler TS ,
Neal ML,
Cross RW,
Woolsey C,
Agans KN,
Borisevich V,
McNamara RP,
Atyeo C,
Roy V,
Germosen D,
Hou F,
Li SL,
Reiserova L,
Choi Y,
Wilson A,
Wagner D,
Wallace-Selman O,
Carpov A,
Geng F,
Frederick DJ,
DeStefano J,
Ercolini AM,
Enriquez AS ,
Hastie KM,
Ramos da Silva S,
Sayeed E,
Coleman JW,
Kilianski A,
Alter G,
Saphire EO ,
Aitchison JD,
Geisbert TW,
Gupta SB,
Feinberg MB,
Parks CL
(2025) Ebiomedicine , 114 , 105647 - 105647
,
Morrow G,
Yuan M,
Postler TS ,
Neal ML,
Cross RW,
Woolsey C,
Agans KN,
Borisevich V,
McNamara RP,
Atyeo C,
Roy V,
Germosen D,
Hou F,
Li SL,
Reiserova L,
Choi Y,
Wilson A,
Wagner D,
Wallace-Selman O,
Carpov A,
Geng F,
Frederick DJ,
DeStefano J,
Ercolini AM,
Enriquez AS ,
Hastie KM,
Ramos da Silva S,
Sayeed E,
Coleman JW,
Kilianski A,
Alter G,
Saphire EO ,
Aitchison JD,
Geisbert TW,
Gupta SB,
Feinberg MB,
Parks CL
(2025) Ebiomedicine , 114 , 105647 - 105647
Grant Support:
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): R01 A1132244 (United States)
- Other private: A08154 (United States)